Katharine Knobil

Officer, Kaleido Biosciences, Inc.

Companies

Korro Bio, Inc.Board member Aug 28, 2024 to now¹
Pliant (United States)Board member Sep 16, 2022 to now²
Marker Therapeutics, Inc.Board member Dec 9, 2021 to now³
Arena PharmaceuticalsBoard member Jun 16, 2020 to Mar 11, 2022⁴
Kaleido Biosciences, Inc.Officer Feb 27, 2019 to Oct 19, 2020⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Marker Therapeutics, Inc. MRKR1,500 shares⁶$1.7K at $1.12Dec 9, 2021
Arena Pharmaceuticals ARNA0 shares⁷Mar 11, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 11, 2022Other 3,882 shares of Arena Pharmaceuticals⁷
Mar 11, 2022Other 2,939 shares of Arena Pharmaceuticals⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARKorro Bio, Inc., Board member
2
SEC EDGARPliant (United States), Board member
3
SEC EDGARMarker Therapeutics, Inc., Board member
4
SEC EDGARArena Pharmaceuticals, Board member
5
SEC EDGARKaleido Biosciences, Inc., Officer
6
SEC EDGARMarker Therapeutics, Inc. shares after the filing of Dec 9, 2021
7
SEC EDGARArena Pharmaceuticals shares after the filing of Mar 11, 2022